antibody-drug conjugate/adc related...antibody-drug conjugates (adcs) are a new class of highly...

www.MedChemExpress.com 1

Inhibitors, Agonists, Screening Librarieswww.MedChemExpress.com

Antibody-drug Conjugate/ADC Related

http://www.MedChemExpress.com

• ADC Cytotoxin 3

• ADC Linker 8

• Drug-Linker Conjugates for ADC 10

Inhibitors, Agonists, Screening Librarieswww.MedChemExpress.com

Target List in Antibody-drug Conjugate/ADC Related

2 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]

http://www.MedChemExpress.com


ADC Cytotoxin

A cytotoxin is any substance which has a toxic effect on cells. Somecommon examples of cytotoxins include chemical agents and certainsnake venoms. Cytotoxins typically attack only a specific type of cellor organ, rather than an entire body. Cells that have been affected bya cytotoxin can perish in several different ways. One is necrosis. In thisform of cell death, the cells lose integrity in their membrane wall andcollapse. Another type of possible cell death is apoptosis. This type ofdeath is pre-programmed into the cell itself before the cytotoxinarrives. It is typically a beneficial property, as seen when cells in thefingers and toes of developing human babies undergo apoptosis,leading to the separation of digits. Chemotherapy as a treatment of

cancer often relies on the ability of these agents to preferentially kill or damage cancer cells as opposed to healthycells.

http://www.medchemexpress.com/Targets/ADC Cytotoxin.html

Purity: 98.56%Clinical Data:Size: 10mM x 1mL in DMSO,

5 mg, 10 mg

Purity: >98%Clinical Data:Size: 10mM x 1mL in DMSO,

1 mg, 5 mg, 10 mg


100 mg, 500 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


5 mg, 10 mg, 50 mg, 100 mg


5 mg, 10 mg, 50 mg, 100 mg

Purity: 95.14%Clinical Data:Size: 1 mg, 5 mg


10 mg, 50 mg

ADC Cytotoxin Inhibitors & Modulators

Bioactivity: 10-Deacetyl-7-xylosyl paclitaxel is a Paclitaxel derivative withimproved pharmacological features and higher water solubility.

Bioactivity: alpha-Amanitin is the principal toxin of several deadly poisonousmushrooms, exerting its toxic function by inhibiting

.RNA-polymerase II

Bioactivity: Ansamitocin P 3' exhibits antitumour activity, is an antibody drugconjugate cytotoxin.

Bioactivity: Ansamitocin P-3 is a inhibitor. Ansamitocin P-3 is amicrotubulemacrocyclic antitumor antibiotic.

Bioactivity: Auristatin E is a cytotoxic tubulin modifier with potent and selectiveantitumor activity; MMAE analog and cytotoxin in Antibody-drugconjugates.

Bioactivity: Auristatin F is a cytotoxic tubulin modifier with potent and selectiveantitumor activity; MMAF analog and cytotoxin in Antibody-drugconjugates.

Bioactivity: Calicheamicin is a potent DNA-damaging cytotoxic agent. Bioactivity: Campathecin is a potent DNA enzyme topoisomerase I (topo I)inhibitor, with and of 50 nM and 0.225 μM in breast cancerIC50 IC70cell line MDA-MB-231.

Bioactivity: D8-MMAE is a deuterated form of MMAE, which is a microtubule-disrupting agent.

Bioactivity: Daun02 is converted by to Daunorubicin, which is a β-galactosidase inhibitor.topoisomerase


10-Deacetyl-7-xylosyl paclitaxel (10-Deacetyl-7-xylosyltaxol; 10-Deacetylpaclitaxel 7-Xyloside; 10-Deacetylt…) Cat. No.: HY-20584

alpha-Amanitin(α-Amanitin; α-Amatoxin) Cat. No.: HY-19610

Ansamitocin P 3'(Antibiotic C 15003P3'; Maytansinol butyrate) Cat. No.: HY-19839

Ansamitocin P-3 (Antibiotic C 15003P3; Maytansinol butyrate; C15003P3) Cat. No.: HY-15739

Auristatin ECat. No.: HY-15582

Auristatin FCat. No.: HY-15583

Calicheamicin(Calicheamicin γ1) Cat. No.: HY-19609

Campathecin((S)-(+)-Camptothecin; CPT) Cat. No.: HY-16560

D8-MMAE(D8-Monomethyl auristatin E; D8-Vedotin; D8 MMAE) Cat. No.: HY-15162A

Daun02(Daun 02; Daun-02) Cat. No.: HY-13061

http://www.medchemexpress.com/Targets/ADC Cytotoxin.htmlhttp://www.medchemexpress.com/10-deacetyl-7-xylosyl-paclitaxel.htmlhttp://www.medchemexpress.com/alpha-Amanitin.htmlhttp://www.medchemexpress.com/Ansamitocin-P-3_acute_.htmlhttp://www.medchemexpress.com/Ansamitocin-P-3.htmlhttp://www.medchemexpress.com/Auristatin-E.htmlhttp://www.medchemexpress.com/Auristatin-F.htmlhttp://www.medchemexpress.com/Calicheamicin.htmlhttp://www.medchemexpress.com/Campathecin.htmlhttp://www.medchemexpress.com/d8-mmae.htmlhttp://www.medchemexpress.com/daun02.html


Purity: >98.00%Clinical Data: Phase 4Size: 10mM x 1mL in DMSO,

5 mg, 10 mg, 50 mg, 100 mg

Purity: 99.69%Clinical Data: Phase 4Size: 10mM x 1mL in DMSO,

100 mg, 500 mg


5 mg, 10 mg, 50 mg

Purity: >95.0%Clinical Data: Phase 1, Phase 2Size: 5 mg, 10 mg, 50 mg, 100 mg


50 mg, 100 mg, 200 mg, 500 mg, 1 g

Purity: >98%Clinical Data:Size: 50 mg, 100 mg, 200 mg, 500 mg

Purity: >98%Clinical Data: Phase 1, Phase 2Size: 5 mg, 10 mg, 50 mg, 100 mg


1 mg, 5 mg

Purity: 99.64%Clinical Data: Phase 4Size: 10mM x 1mL in Water,

10 mg, 50 mg, 100 mg, 200 mg, 500 mg

Purity: >98%Clinical Data:Size: 10 mg, 50 mg

Bioactivity: Daunorubicin(RP13057) inhibits both DNA and RNA synthesis andinhibits DNA synthesis with Ki of 0

Bioactivity: Daunorubicin hydrochloride is a inhibitor.topoisomerase II

Bioactivity: Dolastatin 10 is a potent antimitotic peptide, isolated from themarine mollusk , that inhibits Dolabela auricularia tubulinpolymerization.

Bioactivity: DOXO-EMCH is a 6-maleimidocaproyl hydrazone derivative ofDoxorubicin, is an albumin binding prodrug.

Bioactivity: Doxorubicin(Adriamycin) is an antibiotic agent that inhibits DNAtopoisomerase II and induces DNA damage and apoptosis

Bioactivity: Topoisomerase IIDoxorubicin hydrochloride is a (Top2) catalyticinhibitor, also is a broad spectrum antibiotic used in the treatment ofcancers, with of 374 nM for Hela cells.IC50

Bioactivity: INNO-206 is a prodrug of the anticancer agent doxorubicin, which isreleased from albumin under acidic conditions.

Bioactivity: Maytansinol inhibits microtubule assembly and induces microtubuledisassembly in vitro.

Bioactivity: Methotrexate is a traditional antagonist, with median offolate IC5078 nM for a 120 h drug exposure in a panel of six pediatric leukemiaand lymphoma cell lines using the sulforhodamine B assay.

Bioactivity: Mitomycin C is a DNA-damaging agent and small-molecule inhibitoreffectively sensitize cancer cells to tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).

Daunorubicin(RP13057; Daunomycin; Rubidomycin) Cat. No.: HY-13062A

Daunorubicin Hydrochloride (RP 13057 Hydrochloride; Daunomycin; RP13057 Hydrochloride; RP-13057 Hydroc…) Cat. No.: HY-13062

Dolastatin 10(DLS 10; NSC 376128; Dolastatin-10) Cat. No.: HY-15580

DOXO-EMCH(Doxorubicin-EMCH) Cat. No.: HY-16261A

Doxorubicin(Adriamycin; Hydroxydaunorubicin) Cat. No.: HY-15142A

Doxorubicin hydrochloride(Adriamycin; Hydroxydaunorubicin hydrochloride) Cat. No.: HY-15142

INNO-206(Aldoxorubicin; INNO 206; INNO206) Cat. No.: HY-16261

Maytansinol(Ansamitocin P-0) Cat. No.: HY-19474

Methotrexate(Amethopterin; CL14377; WR19039) Cat. No.: HY-14519

Mitomycin C(Ametycine) Cat. No.: HY-13316

http://www.medchemexpress.com/daunorubicin.htmlhttp://www.medchemexpress.com/Daunorubicin-Hydrochloride.htmlhttp://www.medchemexpress.com/Dolastatin-10.htmlhttp://www.medchemexpress.com/DOXO-EMCH.htmlhttp://www.medchemexpress.com/Doxorubicin.htmlhttp://www.medchemexpress.com/Doxorubicin-hydrochloride.htmlhttp://www.medchemexpress.com/INNO-206.htmlhttp://www.medchemexpress.com/Maytansinol.htmlhttp://www.medchemexpress.com/Methotrexate.htmlhttp://www.medchemexpress.com/Mitomycin-C.html


5 mg, 10 mg, 50 mg


1 mg, 5 mg, 10 mg, 50 mg


1 mg, 5 mg, 10 mg


50 mg, 100 mg, 500 mg


1 mg, 5 mg, 10 mg, 50 mg, 100 mg


2 mg, 5 mg, 10 mg


2 mg, 5 mg, 10 mg

Purity: >98%Clinical Data:Size: 2 mg, 5 mg, 10 mg


10 mg, 50 mg, 100 mg


5 mg, 10 mg, 50 mg, 100 mg

Bioactivity: MMAD is a potent inhibitor, is a toxin payload in antibodytubulindrug conjugates ( ).ADCs

Bioactivity: Monomethyl auristatin D Hcl (MMAD Hcl), a potent tubulin inhibitor,is a toxin payload in antibody drug conjugate.

Bioactivity: MMAF is an antitubulin agent that inhibit cell division; inhibits H3397cell growth with an of 105 nM.IC50

Bioactivity: MMAF hydrochloride is an antitubulin agent that inhibit cell division;inhibits H3397 cell growth with an of 105 nM.IC50

Bioactivity: MMAF-Ome belongs to ADC, and inhibits several tumor cell lineswith s of 0.056 nM, 0.166 nM, 0.183 nM, and 0.449 nM forIC50MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji (5T4 ) cell-

lines, respectively.

Bioactivity: Monomethyl auristatin E (MMAE) is an antimitotic agent whichinhibits cell division by blocking the polymerisation of , andtubulinalso shows inhibition of antibody-drug conjugates ( ) activity.ADCs

Bioactivity: Paclitaxel is a potent anticancer agent known to promote assembly, inhibit MT depolymerization, andmicrotubule (MT)

change MT dynamics required for mitosis and cell proliferation.

Bioactivity: PF-06380101 is a novel cytotoxic Dolastatin 10 analogue; withexcellent potencies in tumor cell proliferation assays and differentialADME properties when compared to other synthetic auristatinanalogues that are used in the preparation of ADCs.

Bioactivity: PNU-159682 is a major bioactive metabolite of Nemorubicin inhuman liver microsomes; > 3,000-fold cytotoxic than its parentcompound(MMDX and doxorubicin).

Bioactivity: Taltobulin (HTI-286; SPA-110) is an analogue of Hemiasterlin; potenttubulin inhibitor; ADCs cytotoxin.


MMAD (Demethyldolastatin 10; Monomethylauristatin D; Monomethyl Dolastatin 10) Cat. No.: HY-15581

MMAD hydrochloride (Demethyldolastatin 10 hydrochloride; Monomethylauristatin D hydrochloride; Monomethyl …) Cat. No.: HY-79105

MMAF(Monomethylauristatin F) Cat. No.: HY-15579

MMAF Hydrochloride(Monomethylauristatin F Hydrochloride) Cat. No.: HY-15579A

MMAF-OMe(Monomethyl auristatin F methyl ester) Cat. No.: HY-79256

Monomethyl auristatin E(Vedotin; MMAE) Cat. No.: HY-15162

PaclitaxelCat. No.: HY-B0015

PF-06380101Cat. No.: HY-12522

PNU-159682(PNU159682; PNU 159682) Cat. No.: HY-16700

Taltobulin (HTI-286; SPA-110; HTI286;SPA110; HTI 286; SPA 110) Cat. No.: HY-15584

http://www.medchemexpress.com/MMAD.htmlhttp://www.medchemexpress.com/MMAD-hydrochloride.htmlhttp://www.medchemexpress.com/mmaf.htmlhttp://www.medchemexpress.com/MMAF-Hydrochloride.htmlhttp://www.medchemexpress.com/MMAF-OMe.htmlhttp://www.medchemexpress.com/Monomethyl-auristatin-E.htmlhttp://www.medchemexpress.com/Paclitaxel.htmlhttp://www.medchemexpress.com/PF-06380101.htmlhttp://www.medchemexpress.com/pnu-159682.htmlhttp://www.medchemexpress.com/taltobulin.html


Purity: >98%Clinical Data: Phase 1Size: 1 mg

Purity: 99.83%Clinical Data: Phase 1, Phase 2Size: 10mM x 1mL in DMSO,

2 mg, 5 mg, 10 mg, 25 mg, 100 mg


5 mg, 10 mg, 50 mg


5 mg, 10 mg, 50 mg

Bioactivity: Taltobulin hydrochloride is an analogue of Hemiasterlin; potenttubulin inhibitor; ADCs cytotoxin.

Bioactivity: Taltobulin trifluoroacetate (HTI-286; SPA-110) is an analogue ofHemiasterlin; potent tubulin inhibitor; ADCs cytotoxin.

Bioactivity: Triptolide is an inhibitor of heat shock factor ( ), inhibitsHSF1HSP90-CDC37 binding and induces acetylation of HSP90, and alsoinhibits expression in a dose-dependent manner with MDM2 IC50values range from 47 to 73 nM.

Bioactivity: Tubulysin A(TubA) is a myxobacterial product that can function as anantiangiogenic agent in many in vitro assays; anti-microtubule,anti-mitotic, an apoptosis inducer, anticancer, anti-angiogenic, andantiproliferative.

Taltobulin hydrochloride(HTI-286 hydrochloride; SPA-110 hydrochloride) Cat. No.: HY-15584B

Taltobulin trifluoroacetate (HTI-286 trifluoroacetate; SPA-110 trifluoroacetate) Cat. No.: HY-15584A

Triptolide(PG490; PG 490; PG-490) Cat. No.: HY-32735

Tubulysin A(TubA) Cat. No.: HY-15995

http://www.medchemexpress.com/Taltobulin-hydrochloride.htmlhttp://www.medchemexpress.com/Taltobulin-trifluoroacetate.htmlhttp://www.medchemexpress.com/Triptolide.htmlhttp://www.medchemexpress.com/Tubulysin-A.html

ADC Linker

Antibody-drug conjugates (ADCs) are a new class of highly potentbiopharmaceutical drugs designed as a targeted therapy for thetreatment of people with cancer. ADCs are complex moleculescomposed of an antibody, a linker and a biological active cytotoxic.ADCs linkers are based on chemical motifs including disulfides,hydrazones or peptides (cleavable), or thioethers (noncleavable) andcontrol the distribution and delivery of the cytotoxic agent to thetarget cell. Cleavable and noncleavable types of linkers have beenproven to be safe in preclinical and clinical trials. A stable linkbetween the antibody and cytotoxic (anti-cancer) agent is a crucialaspect of an ADC.


http://www.medchemexpress.com/Targets/ADC Linker.html



100 mg, 500 mg, 1 g


10 mg, 50 mg, 100 mg, 200 mg


50 mg, 100 mg


5 mg, 10 mg, 50 mg, 100 mg


1 g


10 mg, 50 mg, 100 mg

Purity: >98%Clinical Data:Size: 5 mg, 10 mg, 50 mg, 100 mg

ADC Linker Inhibitors & Modulators

Bioactivity: (Ac)Phe-Lys(Alloc)-PABC-PNP is a useful chemical linker in antibodydrug conjugates.

Bioactivity: 6-Maleimidohexanoic acid N-hydroxysuccinimide ester(ECMS) is auseful protective group in antibody drug conjugates.

Bioactivity: 6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)- is an usefullinker for antibody-drug-conjugations (ADCs), extracted from [BioorgChem. 2012 Apr-Jun;41-42:1-5.] compound 1i.

Bioactivity: Fmoc-Val-Cit-PAB is a linker for antibody-drug-conjugation (ADC).

Bioactivity: Fmoc-Val-Cit-PAB-PNP is a peptide prodrug linker, is a linker forantibody-drug-conjugation (ADC).

Bioactivity: Mc-Val-Cit-PABC-PNP is a cathepsin cleavable ADC peptide linker.FDA approved drug, brentuximab vedotin, adopts this linker.

Bioactivity: Val-cit-PAB-OH is a peptide prodrug linker.

(Ac)Phe-Lys(Alloc)-PABC-PNPCat. No.: HY-20560

6-Maleimidohexanoic acid N-hydroxysuccinimide ester(EMCS) Cat. No.: HY-78961

6-Quinoxalinecarboxylic acid, 2,3-bis(bromomethyl)-Cat. No.: HY-21210

Fmoc-Val-Cit-PABCat. No.: HY-19318

Fmoc-Val-Cit-PAB-PNPCat. No.: HY-41189

Mc-Val-Cit-PABC-PNP (Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate) Cat. No.: HY-20336

Val-cit-PAB-OHCat. No.: HY-12362

http://www.medchemexpress.com/Targets/ADC Linker.htmlhttp://www.medchemexpress.com/_ac_phe-lys_alloc_-pabc-pnp.htmlhttp://www.medchemexpress.com/6-maleimidohexanoic-acid-n-hydroxysuccinimide-ester.htmlhttp://www.medchemexpress.com/6-Quinoxalinecarboxylic-acid,-2,3-bis_bromomethyl_-.htmlhttp://www.medchemexpress.com/Fmoc-Val-Cit-PAB.htmlhttp://www.medchemexpress.com/Fmoc-Val-Cit-PAB-PNP.htmlhttp://www.medchemexpress.com/Mc-Val-Cit-PABC-PNP.htmlhttp://www.medchemexpress.com/Val-cit-PAB-OH.html

Drug-Linker Conjugates for ADC


http://www.medchemexpress.com/Targets/Drug-Linker Conjugates for ADC.html



1 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg


2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg

Purity: >98%Clinical Data:Size: 1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg

Purity: >98%Clinical Data:Size: 1 mg


1 mg, 5 mg, 10 mg

Drug-Linker Conjugates for ADC Inhibitors & Modulators

Bioactivity: Acetylene-linker-Val-Cit-PABC-MMAE consists the ADCs linker(Acetylene-linker-Val-Cit-PABC) and potent tubulin inhibitor (MMAE),Acetylene-linker-Val-Cit-PABC-MMAE is an antibody drug conjugate.

Bioactivity: Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is atoxin payload in antibody drug conjugate.

Bioactivity: Fmoc-Val-Cit-PAB-MMAE consists the ADCs linker(Fmoc-Val-Cit-PAB) and potent tubulin inhibitor (MMAE),Fmoc-Val-Cit-PAB-MMAE is an antibody drug conjugate.

Bioactivity: MAL-di-EG-Val-Cit-PAB-MMAE consists the ADCs linker(MAL-di-EG-Val-Cit-PAB) and potent inhibitor (MMAE),tubulinMAL-di-EG-Val-Cit-PAB-MMAE is an antibody drug conjugate.

Bioactivity: Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is atoxin payload in antibody drug conjugate; Mc-MMAD is a protectivegroup (maleimidocaproyl) -conjugated MMAD.

Bioactivity: Mc-MMAE is a protective group (maleimidocaproyl)-conjugatedmonomethyl auristatin E (MMAE), which is a potent inhibitor,tubulinis a toxin payload in antibody drug conjugate ( ).ADC

Bioactivity: Mc-MMAF is a protective group-conjugated MMAF. MMAF is a morepotent drug than Monomethyl auristatin E (MMAE), but is chargedand relatively membrane-impermeable, is a potent tubulin inhibitor,is a toxin payload in antibody drug conjugate.

Bioactivity: mDPR-Val-Cit-PAB-MMAE consists the ADCs linker(mDPR-Val-Cit-PAB) and potent tubulin inhibitor (MMAE),mDPR-Val-Cit-PAB-MMAE is an antibody drug conjugate.

Bioactivity: Mertansine is a tubulin inhibitorinhibits the assemblyof microtubulesby binding to tubulin, with a linker structure can create anantibody-drug conjugate (ADC).

Bioactivity: SMCC-DM1 is DM1 with a reactive linker SMCC to make antibodydrug conjugate. DM1 (mertansine), a thiol-containing maytansinoid,is a potent microtubule-disrupting agent.

Acetylene-linker-Val-Cit-PABC-MMAE(LCB14-0602) Cat. No.: HY-19812

Cys-mcMMADCat. No.: HY-15750

Fmoc-Val-Cit-PAB-MMAECat. No.: HY-19811

MAL-di-EG-Val-Cit-PAB-MMAECat. No.: HY-100567

Mc-MMAD(Mc MMAD; McMMAD) Cat. No.: HY-15740

Mc-MMAE (Maleimidocaproyl-monomethylauristatin E; Mc MMAE; McMMAE) Cat. No.: HY-15741

McMMAF(mc-MMAF; Maleimidocaproyl monomethylauristatin F) Cat. No.: HY-15578

mDPR-Val-Cit-PAB-MMAECat. No.: HY-19813

Mertansine (DM1; Maytansinoid DM1; DM-1; Maytansinoid DM-1; DM 1;Maytansinoid DM 1) Cat. No.: HY-19792

SMCC-DM1(DM1-SMCC) Cat. No.: HY-101070

http://www.medchemexpress.com/Targets/Drug-Linker Conjugates for ADC.htmlhttp://www.medchemexpress.com/Acetylene-linker-Val-Cit-PABC-MMAE.htmlhttp://www.medchemexpress.com/cys-mcmmad.htmlhttp://www.medchemexpress.com/Fmoc-Val-Cit-PAB-MMAE.htmlhttp://www.medchemexpress.com/MAL-di-EG-Val-Cit-PAB-MMAE.htmlhttp://www.medchemexpress.com/Mc-MMAD.htmlhttp://www.medchemexpress.com/Mc-MMAE.htmlhttp://www.medchemexpress.com/McMMAF.htmlhttp://www.medchemexpress.com/mDPR-Val-Cit-PAB-MMAE.htmlhttp://www.medchemexpress.com/Mertansine.htmlhttp://www.medchemexpress.com/SMCC-DM1.html


1 mg, 5 mg, 10 mg, 50 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg


1 mg, 5 mg, 10 mg

Bioactivity: SuO-Val-Cit-PAB-MMAE is a bydrug-linker conjugate for ADCusing the anti-mitotic agent, monomethyl auristatin E (MMAE), linkedvia the peptide SuO-Val-Cit-PAB.

Bioactivity: Val-Cit-PAB-MMAE is a by using thedrug-linker conjugate for ADCanti-mitotic agent, monomethyl auristatin E (MMAE), linked via thepeptide Val-Cit-PAB.

Bioactivity: Vc-MMAD consists the ADCs linker(Val-Cit) and potent tubulininhibitor (MMAD), Vc-MMAD is an antibody drug conjugate

Bioactivity: VcMMAE is a with potent antitumordrug-linker conjugate for ADCactivity by using the anti-mitotic agent, monomethyl auristatin E(MMAE), linked via the lysosomally cleavable dipeptide,valine-citrulline (vc).


SuO-Val-Cit-PAB-MMAECat. No.: HY-100566

Val-Cit-PAB-MMAECat. No.: HY-100374

Vc-MMAD(Vc MMAD; VcMMAD) Cat. No.: HY-15742

VcMMAECat. No.: HY-15575
http://www.medchemexpress.com/SuO-Val-Cit-PAB-MMAE.htmlhttp://www.medchemexpress.com/Val-Cit-PAB-MMAE.htmlhttp://www.medchemexpress.com/Vc-MMAD.htmlhttp://www.medchemexpress.com/VcMMAE.html

antibody-drug conjugate/adc related...antibody-drug conjugates (adcs) are a new class of highly...

Documents